General project information
Dernière mise à jour: 2021-12-21 12:23
Project name
Real world data collection on the efficacy and drug usage of Raxone 150 mg 180 film-coated tablets for treatment of reduced vision in adolescent and adult patients with Leber’s hereditary optic neuropathy
Project abbreviation
Raxone MEA
Project code
HDP0239
Primary organization that oversees implementation of project
Chiesi Pharmaceuticals
Partner organization participating in project
...
Organisation that commissioned this project
National Institute for Health and Disability Insurance (RIZIV-INAMI)
Organisation providing monetary or material support
Chiesi Pharmaceuticals
Brief project description
....
Regulatory framework of this project
....
docs.healthdata.be